Axsome Therapeutics Earning Date (AXSM)

USA |NASDAQ |USD

AXSM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 8, 2022 Jun 2022 - $-1.03 $-0.86
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 8, 2022 Jun 2022 - $0.00 $0.00

Axsome Therapeutics's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.

AXSM Earnings Date & History Chart

AXSM Earnings & Revenue Forecast

AXSM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 14 $-3.89 $-5.68 $-3.00

AXSM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $-3.89 $-3.90 $-3.91

AXSM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 15 $34.68M $0.00 $104.00M

AXSM Earnings Date & Revenue History

AXSM Earnings History

|
Show More
Show More

AXSM Revenue History

|
Show More
Show More

Axsome Therapeutics Next Earnings Date & Report

AXSM Next Earnings Date & Report Preview: Jun 2022 (FQ)

AXSM's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.

The average EPS estimation for Axsome Therapeutics's next quarterly earnings is $-1.16.

Axsome Therapeutics Previous Earnings Dates & Reports

AXSM Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Axsome Therapeutics's previous earnings date was May 2, 2022 for its fiscal quarter ended Mar 31, 2022.

AXSM's earnings per share (EPS) was $-1.03, missing the consensus analysts forecast of $-1.00 by -3.00%.

The EPS was lower than the previous fiscal quarter (Dec 2021) by 14.44%, and lower than the same period a year before (Mar 2021) by 32.05%.

Revenues were $0.00.

The company reported a net income of $-39.63M.

Free cash flow for the quarter was $-32.87M , compared to $-28.53M last quarter and $-27.25M a year before.

AXSM ended the quarter with $50.28M in total debt, an increase of 8000.84% compared to the previous quarter, and an increase of 0.97% compared to the same quarter a year before.

AXSM Previous Earnings Date & Report Recap: Dec 2021 (FY)

Axsome Therapeutics's previous annual earnings date was Mar 1, 2022 for its fiscal year ended Dec 31, 2021.

AXSM's earnings per share (EPS) was $-3.47, beating the consensus analysts forecast of $-3.59 by -3.34% , and lower than the previous year's EPS (Dec 2020) by 27.01%.

Revenues were $0.00.

The company reported a net income of $-130.40B.

Axsome Therapeutics reported a free cash flow of $-108.23M for its fiscal year, compared to $-78.50M a year ago.

The company ended the fiscal year with $620.67K in total debt, a decrease of -98.75% compared to the previous year.